Successful COVID-19 vaccine delivery requires strong tech partnerships
There are currently two COVID-19 vaccines under accelerated review by the U.S. Food and Drug Administration and European regulatory authorities that have reported safety and efficacy data in phase three clinical trials.1 Unlike the common flu vaccine, each of these COVID-19 vaccines poses similar and unique challenges in terms of procurement, distribution, administration and management. Technology plays an essential role in the secure, safe and equitable distribution of the vaccine and strategic partnerships will enable us to achieve our goals and meet the challenges ahead. In this blog, we will go into more detail on some strategic partnerships that are enabling the delivery of the COVID-19 vaccine.
Partnering towards better outcomes
With COVID-19 vaccines soon to be available, Microsoft and its partners are actively working with customers to deploy vaccine management solutions that enable registration capabilities for patients and providers, phased scheduling for vaccinations, streamlined reporting, and management dashboarding with analytics and forecasting.
Microsoft Consulting Services (MCS) has deployed over 230 emergency COVID-19 response missions globally since the pandemic began in March, including recent engagements to ensure the equitable, secure and efficient distribution of the COVID-19 vaccine. MCS has developed an offering, the Vaccination Registration and Administration Solution (VRAS), which advances the capabilities of their COVID-19 solution portfolio and enables compliant administration of resident assessment, registration and phased scheduling for vaccine distribution.
Collaborating toward a successful outcome
To achieve the goal of an efficient, equitable and safe delivery of the COVID-19 vaccine, close collaboration across agencies and partners will be the key to success.
Microsoft and its partners are committed to doing our part to help the global community address this historic challenge. Together, we look forward to helping our customers embrace the power of digital, and the power of human innovation to deliver a safe and effective vaccine in a prioritized manner.
Dec 11, 2020 at 16:17